Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/onc2011235.

Title:
Disruption of Tacc3 function leads to in vivo tumor regression | Oncogene
Description:
The formation of the bipolar spindle is responsible for accurate chromosomal segregation during mitosis. The dynamic instability of microtubules has an important role in this process, and has been shown to be an effective target for cancer chemotherapy. Several agents that target non-microtubule mitotic proteins, including the motor protein Eg5, Aurora kinases and Polo-like kinases, are currently being developed as chemotherapeutic drugs. However, because the efficacies of these drugs remain elusive, new molecular targets that have essential roles in tumor cells are desired. Here, we provide in vivo evidence that transforming acidic coiled-coil-3 (Tacc3) is a potential target for cancer chemotherapy. Using MRI, we showed that Tacc3 loss led to the regression of mouse thymic lymphoma in vivo, which was accompanied by massive apoptosis. By contrast, normal tissues, including the thymus, showed no overt abnormalities, despite high Tacc3 expression. in vitro analysis indicated that Tacc3 depletion induced multi-polar spindle formation, which led to mitotic arrest, followed by apoptosis. Similar responses have been observed in Burkitt
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {πŸ”}

pubmed, article, google, scholar, cas, cancer, tacc, cell, central, nature, oncogene, spindle, biol, protein, supplementary, cells, access, tumor, research, japan, function, content, noda, microtubule, human, centrosomal, essential, cookies, information, mitotic, lymphoma, expression, nat, figure, jpg, privacy, vivo, regression, yao, mitosis, microtubules, target, molecular, targeting, centrosome, gergely, data, natsume, saiki, formation,

Topics {βœ’οΈ}

nature portfolio permissions reprints privacy policy nature 445 nature advertising social media paclitaxel-induced cell death transforming acidic coiled-coil-3 transforming acidic coiled-coil cancer research spindle-dependent chromosome alignment small-cell lung cancer personal data centrosomal protein d-tacc fission yeast alp14/tog author correspondence ch-tog/xmap215 protein springerlink instant access centrosome-dependent microtubule assembly data protection tacc-ling microtubule dynamics permissions normal development advanced development drosophila meiotic spindles tacc3 depletion sensitizes human disease models chronic lymphocytic leukemia spindle cell features privacy supplementary figure s2 supplementary figure s3 supplementary figure s4 supplementary figure s5 supplementary figure s6 p53-mutant mice tacc domain identifies small molecules degrading lymphoma cell lines spindle pole organization centrosome amplification motor protein eg5 ch-tog/xmap215 centrosomal protein tacc3 highly conserved regions development explore content subscription content bipolar spindle formation

Questions {❓}

  • Targeted antimitotic therapies: can we improve on tubulin agents?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Disruption of Tacc3 function leads to in vivo tumor regression
         description:The formation of the bipolar spindle is responsible for accurate chromosomal segregation during mitosis. The dynamic instability of microtubules has an important role in this process, and has been shown to be an effective target for cancer chemotherapy. Several agents that target non-microtubule mitotic proteins, including the motor protein Eg5, Aurora kinases and Polo-like kinases, are currently being developed as chemotherapeutic drugs. However, because the efficacies of these drugs remain elusive, new molecular targets that have essential roles in tumor cells are desired. Here, we provide in vivo evidence that transforming acidic coiled-coil-3 (Tacc3) is a potential target for cancer chemotherapy. Using MRI, we showed that Tacc3 loss led to the regression of mouse thymic lymphoma in vivo, which was accompanied by massive apoptosis. By contrast, normal tissues, including the thymus, showed no overt abnormalities, despite high Tacc3 expression. in vitro analysis indicated that Tacc3 depletion induced multi-polar spindle formation, which led to mitotic arrest, followed by apoptosis. Similar responses have been observed in Burkitt's lymphoma and T-ALL. These results show that Tacc3 is a vulnerable component of the spindle assembly in lymphoma cells and is a promising cancer chemotherapy target.
         datePublished:2011-06-20T00:00:00Z
         dateModified:2011-06-20T00:00:00Z
         pageStart:135
         pageEnd:148
         sameAs:https://doi.org/10.1038/onc.2011.235
         keywords:
            TACC3
            mitosis
            spindle
            p53
            tumor regression
            Medicine/Public Health
            general
            Internal Medicine
            Cell Biology
            Human Genetics
            Oncology
            Apoptosis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig6_HTML.jpg
         isPartOf:
            name:Oncogene
            issn:
               1476-5594
               0950-9232
            volumeNumber:31
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:R Yao
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Y Natsume
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y Saiki
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
                     name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
                     address:
                        name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H Shioya
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K Takeuchi
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Pathology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T Yamori
               affiliation:
                     name:Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research
                     address:
                        name:Division of Molecular Pharmacology, Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H Toki
               affiliation:
                     name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
                     address:
                        name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I Aoki
               affiliation:
                     name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
                     address:
                        name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T Saga
               affiliation:
                     name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
                     address:
                        name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T Noda
               affiliation:
                     name:Cancer Institute, The Japanese Foundation for Cancer Research
                     address:
                        name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
                     name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
                     address:
                        name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Disruption of Tacc3 function leads to in vivo tumor regression
      description:The formation of the bipolar spindle is responsible for accurate chromosomal segregation during mitosis. The dynamic instability of microtubules has an important role in this process, and has been shown to be an effective target for cancer chemotherapy. Several agents that target non-microtubule mitotic proteins, including the motor protein Eg5, Aurora kinases and Polo-like kinases, are currently being developed as chemotherapeutic drugs. However, because the efficacies of these drugs remain elusive, new molecular targets that have essential roles in tumor cells are desired. Here, we provide in vivo evidence that transforming acidic coiled-coil-3 (Tacc3) is a potential target for cancer chemotherapy. Using MRI, we showed that Tacc3 loss led to the regression of mouse thymic lymphoma in vivo, which was accompanied by massive apoptosis. By contrast, normal tissues, including the thymus, showed no overt abnormalities, despite high Tacc3 expression. in vitro analysis indicated that Tacc3 depletion induced multi-polar spindle formation, which led to mitotic arrest, followed by apoptosis. Similar responses have been observed in Burkitt's lymphoma and T-ALL. These results show that Tacc3 is a vulnerable component of the spindle assembly in lymphoma cells and is a promising cancer chemotherapy target.
      datePublished:2011-06-20T00:00:00Z
      dateModified:2011-06-20T00:00:00Z
      pageStart:135
      pageEnd:148
      sameAs:https://doi.org/10.1038/onc.2011.235
      keywords:
         TACC3
         mitosis
         spindle
         p53
         tumor regression
         Medicine/Public Health
         general
         Internal Medicine
         Cell Biology
         Human Genetics
         Oncology
         Apoptosis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2011.235/MediaObjects/41388_2012_Article_BFonc2011235_Fig6_HTML.jpg
      isPartOf:
         name:Oncogene
         issn:
            1476-5594
            0950-9232
         volumeNumber:31
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:R Yao
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Y Natsume
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y Saiki
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
                  name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
                  address:
                     name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H Shioya
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K Takeuchi
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Pathology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T Yamori
            affiliation:
                  name:Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research
                  address:
                     name:Division of Molecular Pharmacology, Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H Toki
            affiliation:
                  name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
                  address:
                     name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I Aoki
            affiliation:
                  name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
                  address:
                     name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T Saga
            affiliation:
                  name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
                  address:
                     name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T Noda
            affiliation:
                  name:Cancer Institute, The Japanese Foundation for Cancer Research
                  address:
                     name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
                  name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
                  address:
                     name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Oncogene
      issn:
         1476-5594
         0950-9232
      volumeNumber:31
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
      address:
         name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.,
         type:PostalAddress
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Pathology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research
      address:
         name:Division of Molecular Pharmacology, Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
      address:
         name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
         type:PostalAddress
      name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
      address:
         name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
         type:PostalAddress
      name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
      address:
         name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
         type:PostalAddress
      name:Cancer Institute, The Japanese Foundation for Cancer Research
      address:
         name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
      address:
         name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:R Yao
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Y Natsume
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Y Saiki
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
            name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
            address:
               name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.,
               type:PostalAddress
            type:Organization
      name:H Shioya
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:K Takeuchi
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Pathology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:T Yamori
      affiliation:
            name:Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research
            address:
               name:Division of Molecular Pharmacology, Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:H Toki
      affiliation:
            name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
            address:
               name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
               type:PostalAddress
            type:Organization
      name:I Aoki
      affiliation:
            name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
            address:
               name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:T Saga
      affiliation:
            name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science
            address:
               name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:T Noda
      affiliation:
            name:Cancer Institute, The Japanese Foundation for Cancer Research
            address:
               name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
            name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN
            address:
               name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:6Current address: Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.,
      name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Department of Pathology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Division of Molecular Pharmacology, Cancer Chemotherapy Center, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
      name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
      name:Diagnostic Imaging Program, Molecular Imaging Center, National Institute of Radiological Science, Chiba, Japan
      name:Department of Cell Biology, Cancer Institute, The Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Team for Advanced Development and Evaluation of Human Disease Models, Bioresource Center, RIKEN, Ibaraki, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {πŸ‘}(1)

External Links {πŸ”—}(190)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.38s.